Johnson & Johnson pauses coronavirus vaccine trial after participant contracts “unexplained illness” | WHAT REALLY HAPPENED

Johnson & Johnson pauses coronavirus vaccine trial after participant contracts “unexplained illness”

Johnson & Johnson is pausing its Wuhan coronavirus (COVID-19) vaccine trial after a study participant fell ill. The halt comes just weeks after the company announced that they were in the final stage of the trials.

In its news release, Johnson & Johnson said that the trial was paused in compliance with regulatory standards after the unnamed participant developed an “unexplained illness.” It also confirmed that the ENSEMBLE independent Data Safety Monitoring Board (DSMB) reviewed the participant’s condition.

“We must respect this participant’s privacy,” the company’s statement reads. “We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information.”

The statement did not say whether the participant received the experimental vaccine or was in the placebo control group.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA